Home > Uncategorized > US wins trade war! China goes generic big time

US wins trade war! China goes generic big time

from Dean Baker

Donald Trump has proved the skeptics wrong, it seems that the American people stand to be big winners as a result of his trade war. The Chinese government announced a major initiative to promote the manufacture and use of generic drugs.

The reason this is potentially a big deal for the United States is that it could mean that China intends to push the envelope in replacing drugs protected by government-granted patent monopolies with drugs sold at free market prices. While the TRIPs provisions of the WTO do require members to respect patents and copyrights, there are flexibilities, such as compulsory licensing, to allow far more competition that what we see in the United States market.

Countries also have varying rules on what items can be patented. For example, India has far more stringent patent rules than the United States so that many drugs that are protected by patents in the U.S. are sold in a free market in India.

This can matter hugely for people in the United States since if China joins India as a mass producer of high quality generic drugs it will become increasingly difficult for the U.S. drug companies to maintain an island of protected prices in the United States. The gap between the patent protected price for drugs like the Hepatitis C drug Solvaldi and new cancer drugs is often more than 100 to 1 (equivalent to a 10,000 percent tariff) and can be as much as 1000 to 1.  

There is an enormous amount of money at stake (in addition to people’s health) if we can get drugs at their free market price. We will spend more than $450 billion this year on prescription drugs that would likely sell for less than $80 billion in a free market. The difference of $370 billion is almost 2.0 percent of GDP. It is more than five times the entire food stamp budget.

We will need to have alternative mechanisms for financing the research and development of new drugs and having these costs shared internationally. But it is not difficult to develop mechanismsthat are more efficient than the anachronistic patent monopoly system. If Trump’s trade war ends pushing us in this direction, the whole will have won.

  1. Rob Reno
    April 5, 2018 at 4:13 pm

    We already must get meds for our daughters migraines from Canada. We are emigrating out of this shithole country dominated by predatory capitalism. Canada’s universities are already producing world class research in science and medicine and that is where our daughters are heading for education and medical career.

  2. Dave Raithel
    April 6, 2018 at 12:30 am

    “[I]f China joins India as a mass producer of high quality generic drugs it will become increasingly difficult for the U.S. drug companies to maintain an island of protected prices in the United States.”

    I have no faith nor reason that Trump and his circle of jerks would not help them. There is no coherence to what they do but racist baiting and dog whistles.

  3. patrick newman
    April 7, 2018 at 12:32 pm

    Is it not true that it is publicly funded academic research that provides the fundamentals for the development of applicable drugs and their spectacular margins?

  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.